Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P160035/S051

EXCOR Pediatric Ventricular Assist Device

Berlin Heart, Inc. · Decision date Jul 18, 2025

FDA DECISIONP160035/S051

What did the FDA approve?

FDA records P160035/S051 as a supplement to PMA P160035, with the supplement type “Real-Time Process”. The recorded decision is approval, dated Jul 18, 2025.

FDA approval order statement

Approval for changes to the mains power failure trigger board, toggle switch, and red flashing alarm LED of the IKUS driving unit
Regulatory pathway
PMA supplement
Supplement type
Real-Time Process
Clinical specialty
Cardiovascular
Decision date
Jul 18, 2025
FDA change category
Change Design/Components/Specifications/Material

FDA source record

Regulatory record facts

Identifier
P160035/S051
Regulatory pathway
PMA supplement
Product code
DSQ
Decision code
APPR
Decision date
Jul 18, 2025
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Ventricular (assist) bypass.

Product code
DSQ
FDA device class
3

For the original device and its historical approval scope, see PMA P160035. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P160035 · Original PMA

    EXCOR Pediatric Ventricular Assist Device

  2. P160035/S051 received

    Application receipt date recorded by FDA.

  3. P160035/S051 · FDA decision

    Real-Time Process

  4. P160035/S052 · Related supplement

    EXCOR Pediatric Ventricular Assist Device

  5. P160035/S055 · Related supplement

    EXCOR Pediatric Ventricular Assist Device

  6. P160035/S059 · Related supplement

    EXCOR Pediatric Ventricular Assist Device

  7. P160035/S058 · Related supplement

    EXCOR Pediatric Ventricular Assist Device

  8. P160035/S057 · Related supplement

    EXCOR Pediatric Ventricular Assist Device

  9. P160035/S060 · Related supplement

    EXCOR Pediatric Ventricular Assist Device

  10. P160035/S054 · Related supplement

    EXCOR Pediatric Ventricular Assist Device

Timeline entries are records held by MedtechLedger for P160035. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P160035

Product / regulatory recordCompanyPathwayDecision dateSource
Berlin Heart, Inc.PMA approvalJun 6, 2017FDA
Berlin Heart, Inc.PMA supplementJul 24, 2025FDA
EXCOR Cannula ClipP160035/S049
Berlin Heart, Inc.PMA supplementSep 12, 2025FDA
Berlin Heart, Inc.PMA supplementDec 19, 2025FDA
Berlin Heart, Inc.PMA supplementAug 5, 2026FDA
Berlin Heart, Inc.PMA supplementSep 1, 2026FDA
Berlin Heart, Inc.PMA supplementOct 1, 2026FDA
Berlin Heart, Inc.PMA supplementOct 14, 2026FDA
Berlin Heart, Inc.PMA supplementOct 23, 2026FDA
Berlin Heart, Inc.PMA supplementOct 28, 2026FDA
Berlin Heart, Inc.PMA supplementOct 30, 2026FDA

Explore the linked device profile

Other records with product code DSQ

Product / regulatory recordCompanyPathwayDecision dateSource
AbbottPMA supplementOct 30, 2026FDA
ABBOTT MEDICALPMA supplementOct 19, 2026FDA
AbbottPMA supplementOct 2, 2026FDA
HeartMate II LVASP060040/S128
ABBOTT MEDICALPMA supplementOct 1, 2026FDA
HeartMate 3 LVASP160054/S135
ABBOTT MEDICALPMA supplementOct 1, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

FDA describes the real-time supplement process as a review route for minor changes to a device, including certain design, software, sterilization or labeling changes.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Berlin Heart, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
9391 Grogan'S Mill Rd., Suite A-6, The Woodlands, TX, 77380

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records